Focal modification of electrical conduction in the heart by viral gene transfer.
about
Parasympathetic response in chick myocytes and mouse heart is controlled by SREBPSelective molecular potassium channel blockade prevents atrial fibrillationCatheter-based antegrade intracoronary viral gene delivery with coronary venous blockade.Cardiac channelopathies.Randomized transcoronary delivery of CD34(+) cells with perfusion versus stop-flow method in patients with recent myocardial infarction: Early cardiac retention of ⁹⁹(m)Tc-labeled cells activity.The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillationFunctional role of inward rectifier current in heart probed by Kir2.1 overexpression and dominant-negative suppression.Antiarrhythmic drugs: new agents and evolving concepts.Cell transplantation and genetic engineering: new approaches to cardiac pathology.Molecular ablation of ventricular tachycardia after myocardial infarction.Gene transfer techniques for cardiac arrhythmias.Effects of sterol regulatory element-binding protein (SREBP) in chickens.Targeted high-efficiency, homogeneous myocardial gene transfer.Cell and gene therapy for arrhythmias: Repair of cardiac conduction damageModification of cellular communication by gene transfer.Gene therapy approaches to ventricular tachyarrhythmias.Biological Heart Rate Reduction Through Genetic Suppression of Gα(s) Protein in the Sinoatrial Node.The Use of Gene Therapy for Ablation of Atrial Fibrillation.Comparison of adeno-associated virus serotypes and delivery methods for cardiac gene transfer.From gene therapy and stem cells to clinical electrophysiology.Targeted nonviral gene-based inhibition of Gα(i/o)-mediated vagal signaling in the posterior left atrium decreases vagal-induced atrial fibrillation.Cardiovascular therapeutic aspects of cell therapy and stem cells.Gene transfer for congestive heart failure: update 2013.Recent insights into the role of the autonomic nervous system in the creation of substrate for atrial fibrillation: implications for therapies targeting the atrial autonomic nervous system.Gene therapy in the treatment of heart failure.Gene therapy for cardiac arrhythmias: a dream soon to come true?Current strategies for myocardial gene delivery.Biological Therapies for Atrial Fibrillation: Ready for Prime Time?Designing heart performance by gene transfer.Gene therapy to treat cardiovascular disease.Targeted SERCA2a gene expression identifies molecular mechanism and therapeutic target for arrhythmogenic cardiac alternans.Engineering proteins for custom inhibition of Ca(V) channels.Gene therapy strategies for cardiac electrical dysfunction.Regenerative therapies in electrophysiology and pacing: introducing the next steps.Targeted gene therapy for the treatment of heart failure.Cardiac gene therapy in large animals: bridge from bench to bedside.Stem cell therapy for electrophysiological disorders.Cellular unfolded protein response against viruses used in gene therapyGene therapy to restore electrophysiological function in heart failure.Gene therapy to treat cardiac arrhythmias.
P2860
Q28591399-594ABE09-9ED3-4375-8AB3-FD6A8E598E97Q33943789-89711D53-84DC-4274-86ED-3D3B7E9B89F0Q34191737-D42EBF08-C46A-4F1F-8ED0-2334C4829C86Q34503400-0326B64C-DEBC-4A0C-A2B3-87220726D80FQ34544884-69EDC3D2-92DF-4AFD-AB0B-3137B7741D1AQ34772923-A4AE71D8-2724-48D4-A2A0-3CB28498C90CQ34997952-36C8AB39-4EBC-4965-8441-8003B77B516EQ35073365-5F111E80-0659-49C5-9B3B-6A4B8C600B1AQ35547250-DFD4E607-3C2F-46A4-99F6-23C7F58C7C4CQ35613114-18999D11-EBCF-4CEA-B403-549A117F5991Q35791493-B3EBF3FA-306D-4571-AFE0-49151431273AQ35834373-77DEB6AD-CE93-4945-BFC5-BEC98FB9B9ADQ35990749-6D6DDFFA-3F7E-49C6-84AF-9BD8089DE1B0Q36077259-4FD2DDAB-7544-4E06-A5D6-B63B038BEBC9Q36225135-C92F4A43-5065-4AD5-956F-D9F320772CA6Q36238863-A78817FE-0030-4D94-8F0F-B9C8C8C7DFCDQ36366373-B059E991-82A7-48CD-862E-9D963A95224DQ36458906-9DFE8D53-F606-46CA-9C13-BC9F959BA7A4Q36563927-8E83C119-BB39-432D-89AA-0AB2C491D665Q36596746-7A650376-2FEA-4C12-BE34-8EF551CB6F8AQ36604734-E882C0F8-EFEB-458A-9E4F-B9B37E061DC5Q36667364-90A568C6-E068-407A-B022-418CC15E45DAQ36698991-8FB679B9-A708-42C8-AA44-7B99C137F6C0Q36713691-67E263B1-D1C4-4A4E-A1F4-C3223624CA1CQ36786243-0B3B7D50-0FCA-4CCC-8305-1D3200BF87DAQ36800517-776D525E-EED0-4AC9-91B8-D95F2DC8B8C5Q36931967-7CDFC613-B923-4AFD-A394-084DD35A9610Q36934761-9B9774D1-08F9-4D2E-A5E7-7F48D1CD6060Q37299072-37F0AE05-4721-402B-87E0-0A45DAFA835BQ37310450-34171F6D-975F-4EF6-91E9-4F71BD19E1D9Q37480953-A57040BC-9656-4028-9088-31A28F892094Q37578943-EF2DD530-1F84-42BD-A0B4-302A4C8632D8Q37778878-B76DB820-1904-4CE0-97E0-21594F370605Q37821376-936272C4-2181-4FD1-8963-52CDFBC1BCE4Q37878086-995016EE-293B-4154-9615-084C45F97F93Q37981008-389DADB7-5085-4A14-B692-A406B45279BAQ38129803-B9282A46-0829-435B-A66A-19CD61415982Q38218111-8F3FC3C6-A093-45FB-B4BE-00DBA078B468Q38416938-83E3AEBF-DBB0-4865-9018-82D072CD97BBQ38444909-ABB3333C-B2E2-4378-BE0E-A977DCD9D688
P2860
Focal modification of electrical conduction in the heart by viral gene transfer.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Focal modification of electrical conduction in the heart by viral gene transfer.
@en
Focal modification of electrical conduction in the heart by viral gene transfer.
@nl
type
label
Focal modification of electrical conduction in the heart by viral gene transfer.
@en
Focal modification of electrical conduction in the heart by viral gene transfer.
@nl
prefLabel
Focal modification of electrical conduction in the heart by viral gene transfer.
@en
Focal modification of electrical conduction in the heart by viral gene transfer.
@nl
P2093
P356
P1433
P1476
Focal modification of electrical conduction in the heart by viral gene transfer.
@en
P2093
Donahue JK
Eschenhagen T
Heldman AW
McDonald AD
P2888
P304
P356
10.1038/82214
P407
P577
2000-12-01T00:00:00Z
P6179
1016566214